Stockscreener 앱 받기
9.36
3.10%
0.33
시간 외 거래:
9.36
Regenxbio Inc 주식(RGNX)의 최신 뉴스
Q3 Earnings Forecast for REGENXBIO Issued By Leerink Partnrs - MarketBeat
REGENXBIO Inc. (NASDAQ:RGNX) Receives $28.38 Consensus Price Target from Analysts - MarketBeat
Is REGENXBIO Inc impacted by rising ratesJuly 2025 PreEarnings & Weekly High Conviction Trade Ideas - خودرو بانک
Aug Chart Watch: Is REGENXBIO Inc stock undervalued right nowRecession Risk & Technical Entry and Exit Alerts - خودرو بانک
MACD Signal: Is REGENXBIO Inc stock undervalued right nowIPO Watch & Precise Swing Trade Entry Alerts - خودرو بانک
Market Rankings: How is REGENXBIO Inc managing supply chain issuesWeekly Trend Recap & Capital Efficient Trading Techniques - خودرو بانک
US Market Wrap: Whats the beta of REGENXBIO Inc stockQuarterly Trade Review & Low Drawdown Investment Ideas - خودرو بانک
Swing Trade: Can REGENXBIO Inc. maintain sales growth2025 Key Lessons & Real-Time Chart Pattern Alerts - خودرو بانک
Profit Review: Is REGENXBIO Inc impacted by rising ratesEarnings Recap Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Investment Review: Is UMH Properties Inc a defensive stockExit Point & Daily Volume Surge Signals - خودرو بانک
Published on: 2025-09-16 04:03:08 - خودرو بانک
Smart Money: Is REGENXBIO Inc stock showing strong momentumJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Aug Macro: Is REGENXBIO Inc stock a good dividend stockEarnings Recap Summary & Free Verified High Yield Trade Plans - خودرو بانک
Exome Asset Management LLC Takes $2.90 Million Position in REGENXBIO Inc. $RGNX - MarketBeat
REGENXBIO (NASDAQ:RGNX) Earns Buy Rating from Chardan Capital - MarketBeat
REGENXBIO (NASDAQ:RGNX) Earns "Buy" Rating from HC Wainwright - MarketBeat
Insider Sell: Curran Simpson Sells Shares of Regenxbio Inc (RGNX) - GuruFocus
Ultragenyx Makes Bid for Dimension TherapeuticsBiotech Movers - TheStreet
Ieq Capital LLC Takes Position in REGENXBIO Inc. $RGNX - MarketBeat
Invesco Ltd. Purchases 27,341 Shares of REGENXBIO Inc. $RGNX - MarketBeat
Patients Treated With REGENXBIO's MPS II Gene Therapy RGX-121 Sustain 82% Median Reduction in CSF HS D2S6 Levels Through 1 Year - CGTLive®
Can REGENXBIO Inc. maintain sales growthInsider Buying & Fast Exit Strategy with Risk Control - Lancaster City Council
Is REGENXBIO Inc. in a long term uptrendTrade Volume Summary & AI Forecast Swing Trade Picks - Lancaster City Council
Regenxbio says FDA extends review date for Hunter syndrome drug - MSN
Regenxbio: Poised For Breakthrough With RGX-121 Gene Therapy In Hunter Syndrome - Seeking Alpha
PDT Partners LLC Buys 39,501 Shares of REGENXBIO Inc. $RGNX - MarketBeat
Regenxbio at Morgan Stanley Conference: Gene Therapy Progress and Financial Strength - Investing.com Canada
Moving Average Crossover Confirms Uptrend in REGENXBIO Inc.July 2025 Summary & Weekly High Conviction Ideas - beatles.ru
Regenxbio stock rating reiterated at Buy by H.C. Wainwright on positive trial data - Investing.com
Pattern Scan Adds REGENXBIO Inc. to WatchlistJuly 2025 Chart Watch & Fast Gaining Stock Strategy Reports - beatles.ru
Trade Report: What is REGENXBIO Inc. s debt to equity ratio2025 Top Gainers & Weekly High Return Forecasts - 뉴스영
124,700 Shares in REGENXBIO Inc. $RGNX Bought by Nuveen LLC - MarketBeat
ADAR1 Capital Management LLC Acquires 162,423 Shares of REGENXBIO Inc. $RGNX - MarketBeat
RegenXBio (RGNX) Receives a Buy from Raymond James - The Globe and Mail
What recovery options are there for REGENXBIO Inc.2025 Risk Factors & Expert Approved Momentum Ideas - Newser
REGENXBIO Inc. recovery potential after sell offAnalyst Downgrade & Safe Entry Zone Identification - Newser
Regenxbio: Remains A "Buy Rating" Despite BLA Review Delay Of RGX-121 For Hunter Syndrome (NASDAQ:RGNX) - Seeking Alpha
Can REGENXBIO Inc. expand into new markets2025 Earnings Surprises & Advanced Technical Signal Analysis - خودرو بانک
Top chart patterns to watch in REGENXBIO Inc.Weekly Investment Recap & AI Optimized Trading Strategy Guides - Newser
Is REGENXBIO Inc.’s ROIC above industry averageTreasury Yields & Real-Time Stock Movement Alerts - خودرو بانک
Goldman Sachs reiterates Neutral rating on Regenxbio stock at $14 target - Investing.com Australia
REGENXBIO reports positive one-year data for MPS II gene therapy - Investing.com Nigeria
Should value investors consider REGENXBIO Inc.2025 Stock Rankings & Daily Stock Trend Reports - خودرو بانک
Goldman Sachs reiterates Neutral rating on Regenxbio stock at $14 target By Investing.com - Investing.com South Africa
Can REGENXBIO Inc. expand its profit marginsWeekly Risk Report & Free Reliable Trade Execution Plans - خودرو بانک
Regenxbio stock maintains Outperform rating at Raymond James on MPS II data - Investing.com Nigeria
Regenxbio stock maintains Outperform rating at Raymond James on MPS II data By Investing.com - Investing.com South Africa
Will REGENXBIO Inc. bounce back from current supportQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser
0.07%
1.39%
자본화:
|
볼륨(24시간):